An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

The delivery method involves specially engineered nanoparticles, tiny bits of matter no larger than 100 billionths of a meter. Tested in a mouse model, the dual peptide ... with cancers of the ovaries ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Computer tomography (CT) data from the Open Source Imaging Consortium (OSIC) database were analyzed and patient-specific models ... lung structure and function were then used to study the delivery ...

Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery ... counterpart is capable of targeting the lungs.

Daily treatment with IPL344 for up to three years was safe and slowed ALS progression in a small Phase 2a clinical trial, ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening ...